• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗新生儿戒断综合征的低比例美沙酮或苯巴比妥儿科口服制剂的设计

Design of pediatric oral formulations with a low proportion of methadone or phenobarbital for the treatment of neonatal abstinence syndrome.

作者信息

Provenza Nora, Calpena Ana C, Mallandrich Mireia, Pueyo Blanca, Clares Beatriz

机构信息

a Pharmacokinetics and Biopharmaceutics Unit , School of Pharmacy, University of Barcelona , Barcelona , Spain and.

b Department of Pharmacy and Pharmaceutical Technology , School of Pharmacy, University of Granada , Granada , Spain.

出版信息

Pharm Dev Technol. 2016 Sep;21(6):755-62. doi: 10.3109/10837450.2015.1055765. Epub 2015 Jul 9.

DOI:10.3109/10837450.2015.1055765
PMID:26155877
Abstract

CONTEXT

Elaboration of oral liquid formulations is the best alternative when no marketed forms are available for pediatrics.

OBJECTIVE

The development, characterization and stability evaluation of methadone (MI, MII, MIII) and phenobarbital (PI, PII) can be used for the treatment of neonatal abstinence syndrome (NAS).

MATERIAL AND METHODS

A standard operating procedure was established and parameters such as appearance, pH, rheological behavior and drug content were evaluated at three temperatures for 90 days.

RESULTS AND DISCUSSION

Changes in color of phenobarbital made necessary the storage below 25 °C. pH did not change in methadone solutions and was able to maintain phenobarbital solubilized. Degradation data at 4 °C fitted to Plateau equation followed by one phase decay. MI was stable for 60 days at the three temperatures; MII for 90 days at 4 and 25 °C and 60 days at 40 °C; MIII for 60 days at 4 °C, 15 days at 25 °C and 7 days at 4 °C. PI was stable for 60 days at 4 °C and 30 days at 25 °C. PII was stable for 7 days at 4 and 25 °C. All solutions met microbial specifications.

CONCLUSION

A correct dosage for the treatment of NAS was guaranteed.

摘要

背景

当没有适用于儿科的市售剂型时,制备口服液体制剂是最佳选择。

目的

美沙酮(MI、MII、MIII)和苯巴比妥(PI、PII)的开发、表征及稳定性评估可用于治疗新生儿戒断综合征(NAS)。

材料与方法

制定了标准操作规程,并在三个温度下评估90天,包括外观、pH值、流变行为和药物含量等参数。

结果与讨论

苯巴比妥颜色变化使得需在25°C以下储存。美沙酮溶液的pH值未改变,且能使苯巴比妥保持溶解状态。4°C下的降解数据符合高原方程并随后呈单相衰减。MI在三个温度下均稳定60天;MII在4°C和25°C下稳定90天,在40°C下稳定60天;MIII在4°C下稳定60天,在25°C下稳定15天,在40°C下稳定7天。PI在4°C下稳定60天,在25°C下稳定30天。PII在4°C和25°C下稳定7天。所有溶液均符合微生物标准。

结论

保证了治疗NAS的正确剂量。

相似文献

1
Design of pediatric oral formulations with a low proportion of methadone or phenobarbital for the treatment of neonatal abstinence syndrome.用于治疗新生儿戒断综合征的低比例美沙酮或苯巴比妥儿科口服制剂的设计
Pharm Dev Technol. 2016 Sep;21(6):755-62. doi: 10.3109/10837450.2015.1055765. Epub 2015 Jul 9.
2
Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey.新生儿重症监护病房中新生儿戒断综合征的管理:一项全国性调查。
J Perinatol. 2006 Jan 1;26(1):15-7. doi: 10.1038/sj.jp.7211427.
3
High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome.孕妇使用高剂量美沙酮及其对新生儿戒断综合征持续时间的影响。
Am J Obstet Gynecol. 2009 Jan;200(1):70.e1-5. doi: 10.1016/j.ajog.2008.08.041. Epub 2008 Oct 30.
4
Management of neonatal abstinence syndrome in neonates born to opioid maintained women.对阿片类药物维持治疗的女性所生新生儿的新生儿戒断综合征的管理。
Drug Alcohol Depend. 2007 Mar 16;87(2-3):131-8. doi: 10.1016/j.drugalcdep.2006.08.024. Epub 2006 Sep 26.
5
Update on the pharmacologic management of neonatal abstinence syndrome.新生儿戒断综合征的药物治疗进展。
J Perinatol. 2011 Nov;31(11):692-701. doi: 10.1038/jp.2011.116. Epub 2011 Aug 25.
6
Effectiveness of a clinical pathway with methadone treatment protocol for treatment of neonatal abstinence syndrome following in utero drug exposure to substances of abuse*.米氮平治疗方案在治疗阿片类物质宫内暴露后新生儿戒断综合征中的临床路径的有效性*。
Pediatr Crit Care Med. 2014 Feb;15(2):162-9. doi: 10.1097/PCC.0b013e3182a12611.
7
Treatment of neonatal abstinence syndrome with clonidine and chloral hydrate.采用可乐定和水合氯醛治疗新生儿戒断综合征。
Acta Paediatr. 2010 Feb;99(2):209-14. doi: 10.1111/j.1651-2227.2009.01547.x. Epub 2009 Oct 19.
8
[Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].[新生儿药物戒断——49例宫内药物暴露婴儿的临床数据:该如何应对?]
Klin Padiatr. 2008 Sep-Oct;220(5):308-15. doi: 10.1055/s-2007-992800. Epub 2008 Feb 7.
9
A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations.一项关于使用美沙酮与口服吗啡制剂治疗新生儿戒断综合征的婴儿住院时间的回顾性研究。
Adv Neonatal Care. 2005 Oct;5(5):265-72. doi: 10.1016/j.adnc.2005.06.003.
10
Stability of dilute oral morphine solution for neonatal abstinence syndrome.用于治疗新生儿戒断综合征的稀释口服吗啡溶液的稳定性。
J Addict Med. 2013 Mar-Apr;7(2):113-5. doi: 10.1097/ADM.0b013e318280f495.

引用本文的文献

1
Development and validation of a HPLC-UV method for methadone hydrochloride quantification in a new oral solution with preservatives to be implemented in physicochemical stability studies.开发并验证一种用于在含有防腐剂的新型口服溶液中定量测定盐酸美沙酮的高效液相色谱-紫外检测法,该方法将用于理化稳定性研究。
BMC Chem. 2022 May 14;16(1):32. doi: 10.1186/s13065-022-00827-9.
2
Physicochemical and Microbiological Stability of Two Oral Solutions of Methadone Hydrochloride 10 mg/mL.盐酸美沙酮 10 毫克/毫升两种口服溶液的理化和微生物稳定性。
Molecules. 2022 Apr 28;27(9):2812. doi: 10.3390/molecules27092812.